dfan0610strategic_united.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A
(Rule 14a-101)
 
INFORMATION REQUIRED IN PROXY STATEMENT
 
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.)
 
Filed by the Registrant o
 
Filed by a Party other than the Registrant x
 
Check the appropriate box:
 
  Preliminary Proxy Statement
   
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
  Definitive Proxy Statement
   
  Definitive Additional Materials
   
  Soliciting Material Under Rule 14a-12
 
UNITED AMERICAN HEALTHCARE CORPORATION 

(Name of Registrant as Specified in Its Charter)


STRATEGIC TURNAROUND EQUITY PARTNERS, LP (CAYMAN)
GALLOWAY CAPITAL MANAGEMENT, LLC
BRUCE GALLOWAY
GARY L. HERMAN
SETH M. LUKASH
FRED ZEIDMAN

(Name of Persons(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):
 
 
1

 
 
  No fee required.
   
 o  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
(1)  
Title of each class of securities to which transaction applies:
 

 
(2)  
Aggregate number of securities to which transaction applies:
 

 
(3)  
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 

 
(4)  
Proposed maximum aggregate value of transaction:
 

 
(5)  
Total fee paid:
 

 
o    Fee paid previously with preliminary materials:


 
        o    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
 
(1)  
Amount previously paid:
 

 
(2)  
Form, Schedule or Registration Statement No.:
 

 
 
2

 
 
(3)  
Filing Party:
 

 
(4)  
Date Filed:
 
 
Strategic Turnaround Equity Partners, LP (Cayman) (“Strategic”), together with the other participants named herein, has made a definitive filing with the Securities and Exchange Commission of a proxy statement and an accompanying GOLD proxy card to be used to solicit votes for the election of its nominees at the 2009 annual meeting of shareholders of United American Healthcare Corporation, a Michigan corporation (the “Company”).
 
On April 5, 2010, Strategic filed the following Emergency Motion for Preliminary Injunction (the “Motion”) in the United States District Court for the Eastern District of Michigan against the Company, Tom Goss, the Company’s Chairman, John Fife and related parties of John Fife.  The Motion seeks injunctive relief from, among other things, implementation of the Voting and Standstill Agreement between the Company and John Fife and his affiliates, including the voting trust and irrevocable proxy established thereunder.
 
 
 
3

 
 
 
 
 
4

 
 
 
5

 
 
 
 
6

 
 
 
7

 
 
 
 
8

 
 
 
9

 
 
 
 
10

 
 
 
 
11

 
 
 
 
12

 
 
 
 
13

 
 
 
 
14

 
 
 
15

 
 
16

 
 
17

 
 
 
18

 
 
 
19

 
 
 
20

 
 
21

 
 
22

 
 
 
23

 
 
 
24

 
 
 
25

 
 
 
26

 
 
 
27

 
 
 
28

 
29

 
 
 
30

 
 
31

 
 
32

 
 
33

 
 
34